DK2337580T3 - Stabiliserede sammensætninger til rekombinant fremstillet faktor VIII - Google Patents

Stabiliserede sammensætninger til rekombinant fremstillet faktor VIII

Info

Publication number
DK2337580T3
DK2337580T3 DK09782562.4T DK09782562T DK2337580T3 DK 2337580 T3 DK2337580 T3 DK 2337580T3 DK 09782562 T DK09782562 T DK 09782562T DK 2337580 T3 DK2337580 T3 DK 2337580T3
Authority
DK
Denmark
Prior art keywords
factor viii
stabilized compositions
recombinantly prepared
prepared factor
recombinantly
Prior art date
Application number
DK09782562.4T
Other languages
English (en)
Inventor
Brita Rippner
Josefin Oesterberg
Ulrika Nilsson
Elsa Ivarsson
Irene Agerkvist
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Application granted granted Critical
Publication of DK2337580T3 publication Critical patent/DK2337580T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK09782562.4T 2008-09-03 2009-09-03 Stabiliserede sammensætninger til rekombinant fremstillet faktor VIII DK2337580T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13640208P 2008-09-03 2008-09-03
EP08163554 2008-09-03
PCT/EP2009/061402 WO2010026186A1 (en) 2008-09-03 2009-09-03 New protecting compositions for recombinantly produced factor viii

Publications (1)

Publication Number Publication Date
DK2337580T3 true DK2337580T3 (da) 2012-07-09

Family

ID=39791048

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09782562.4T DK2337580T3 (da) 2008-09-03 2009-09-03 Stabiliserede sammensætninger til rekombinant fremstillet faktor VIII

Country Status (19)

Country Link
US (4) US20110178019A1 (da)
EP (1) EP2337580B1 (da)
JP (2) JP5960990B2 (da)
KR (3) KR20110073434A (da)
CN (3) CN107050437A (da)
AT (1) ATE551050T1 (da)
AU (1) AU2009289212B2 (da)
BR (1) BRPI0918589B1 (da)
CA (1) CA2735376C (da)
DK (1) DK2337580T3 (da)
ES (1) ES2382443T3 (da)
IL (1) IL211083A (da)
MX (1) MX2011002316A (da)
PL (1) PL2337580T3 (da)
PT (1) PT2337580E (da)
RU (1) RU2510279C3 (da)
SI (1) SI2337580T1 (da)
WO (1) WO2010026186A1 (da)
ZA (1) ZA201101605B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1820516B1 (en) 1999-02-22 2013-07-24 University of Connecticut Novel albumin-free factor VIII formulations
CA2742328C (en) 2008-11-07 2019-02-26 Baxter International Inc. Factor viii formulations
CN102232932B (zh) * 2010-04-27 2013-06-05 重庆莱美药业股份有限公司 果胶-阿霉素轭合物的冻干制剂及制备方法
CA2918369C (en) * 2013-07-18 2021-06-29 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
EP3097118B1 (en) 2014-01-20 2018-07-18 Octapharma AG A process for manufacturing factor viii having an improved ratio of fviii:c/fviii:ag
MX2017000862A (es) * 2014-08-04 2017-05-01 Csl Ltd Formulacion de factor viii.
CN113171447B (zh) 2014-08-20 2024-05-17 博尔托拉制药公司 Xa因子解毒剂的冻干制剂
US20190046450A1 (en) * 2016-02-24 2019-02-14 Portola Pharmaceuticals, Inc. Lyophilized formulations for factor xa antidote
EP3443346B1 (en) * 2016-04-13 2023-08-30 Medimmune, LLC Use of amino acids as stabilizing compounds in pharmaceutical compositions containing high concentrations of protein-based therapeutic agents
EP4013389A1 (en) 2019-08-16 2022-06-22 Octapharma AG Stabilizing buffer for factor viii and vwf
CN116479088A (zh) * 2022-11-15 2023-07-25 江苏默乐生物科技股份有限公司 一种生物试剂冻干保存的试剂组合、试剂盒、方法及应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605884A (en) * 1987-10-29 1997-02-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Factor VIII formulations in high ionic strength media
US4877608A (en) * 1987-11-09 1989-10-31 Rorer Pharmaceutical Corporation Pharmaceutical plasma protein formulations in low ionic strength media
DE4001451A1 (de) * 1990-01-19 1991-08-01 Octapharma Ag Stabile injizierbare loesungen von faktor viii und faktor ix
DE4111393A1 (de) * 1991-04-09 1992-10-15 Behringwerke Ag Stabilisierte faktor viii-praeparationen
US5288853A (en) * 1992-04-30 1994-02-22 Alpha Therapeutic Corporation Factor viii purification process
NZ256921A (en) * 1992-10-02 1996-05-28 Pharmacia Ab Formulations of coagulation factor viii and a non-ionic surfactant and their preparation
SE9301581D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Protein formulation
SE9403915D0 (sv) * 1994-11-14 1994-11-14 Annelie Almstedt Process A
US5763401A (en) * 1996-07-12 1998-06-09 Bayer Corporation Stabilized albumin-free recombinant factor VIII preparation having a low sugar content
US6005007A (en) * 1997-07-18 1999-12-21 Farmer; Luc J. Retinoids, methods for their production and use
US6358703B1 (en) * 1998-12-10 2002-03-19 Bayer Corporation Expression system for factor VIII
EP1820516B1 (en) * 1999-02-22 2013-07-24 University of Connecticut Novel albumin-free factor VIII formulations
ATE264340T1 (de) * 1999-08-17 2004-04-15 Novo Nordisk Healthcare Ag Stabilisierung von gefriergetrocknetem kuchen
SE0004086D0 (sv) * 2000-11-08 2000-11-08 Pharmacia Ab Preparation process
GB0207092D0 (en) * 2002-03-26 2002-05-08 Sod Conseils Rech Applic Stable pharmaceutical composition containing factor VIII
KR101235507B1 (ko) * 2003-02-28 2013-02-20 추가이 세이야쿠 가부시키가이샤 단백질을 함유하는 안정화 제제
KR100624013B1 (ko) * 2004-06-25 2006-09-19 주식회사 녹십자홀딩스 동결건조된 알부민 비함유 재조합 사람 혈액응고 제 8인자 제제
JP2008534559A (ja) * 2005-04-01 2008-08-28 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 血液凝固ｆｖｉｉｉ類似体
CN101415445A (zh) * 2006-03-31 2009-04-22 巴克斯特国际公司 聚乙二醇化的因子ⅷ
WO2008073620A2 (en) * 2006-11-02 2008-06-19 Neose Technologies, Inc. Manufacturing process for the production of polypeptides expressed in insect cell-lines
WO2009006301A2 (en) * 2007-06-29 2009-01-08 Battelle Memorial Institute Protein stabilization
KR20160104740A (ko) * 2008-06-24 2016-09-05 옥타파마 아게 응고 인자 ｖｉｉｉ을 정제하는 방법
JP2012503637A (ja) * 2008-09-24 2012-02-09 スタビリテック リミテッド 糖およびポリエチレンイミンを使用するポリペプチドの保存方法

Also Published As

Publication number Publication date
MX2011002316A (es) 2011-05-10
CN107050437A (zh) 2017-08-18
JP2015129158A (ja) 2015-07-16
JP6010155B2 (ja) 2016-10-19
ES2382443T3 (es) 2012-06-08
EP2337580A1 (en) 2011-06-29
SI2337580T1 (sl) 2012-06-29
PL2337580T3 (pl) 2012-08-31
JP2012502004A (ja) 2012-01-26
AU2009289212B2 (en) 2015-02-12
CN107049964B (zh) 2020-06-02
ATE551050T1 (de) 2012-04-15
ZA201101605B (en) 2011-10-26
RU2011112787A (ru) 2012-10-10
JP5960990B2 (ja) 2016-08-02
WO2010026186A1 (en) 2010-03-11
US20190358301A1 (en) 2019-11-28
CN107049964A (zh) 2017-08-18
EP2337580B1 (en) 2012-03-28
IL211083A (en) 2016-09-29
PT2337580E (pt) 2012-05-28
AU2009289212A1 (en) 2010-03-11
RU2510279C2 (ru) 2014-03-27
CN102143759A (zh) 2011-08-03
RU2510279C3 (ru) 2017-04-17
US20110178019A1 (en) 2011-07-21
KR20160114194A (ko) 2016-10-04
CA2735376A1 (en) 2010-03-11
IL211083A0 (en) 2011-07-31
CA2735376C (en) 2016-11-29
US20150190478A1 (en) 2015-07-09
BRPI0918589A2 (pt) 2017-04-11
KR20160093743A (ko) 2016-08-08
BRPI0918589B1 (pt) 2021-07-13
KR20110073434A (ko) 2011-06-29
KR101691070B1 (ko) 2016-12-29
KR101691443B1 (ko) 2016-12-30
US20170189494A1 (en) 2017-07-06

Similar Documents

Publication Publication Date Title
DK2337580T3 (da) Stabiliserede sammensætninger til rekombinant fremstillet faktor VIII
JOP20180103B1 (ar) التركيب الصيدلاني للكاربيتوسين
MY162760A (en) Anti-infective agents and uses thereof
TN2012000010A1 (en) Long acting insulin composition
BR112015011244A8 (pt) análogos de compstatina de reação celular, ação longa ou direcionados e composições e métodos relacionados
DK2203430T3 (da) N-phenyl-dioxo-hydropyrimidiner anvendelige som inhibitorer for hepatitis C virus (HCV)
GT200800184A (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevencion de diabetes.
MX2013004162A (es) Composiciones farmaceuticas que contienen un inhibidor de dgat1.
MX2008015989A (es) Composicion espumante para alta temperatura y salinidad.
BR112013028816A2 (pt) "análogos de compstatina, composição que os compreende e uso dos mesmos".
UA94606C2 (ru) Производные тиоксантина, композиция, которая их содержит, и их применение в терапии
PE20151717A1 (es) Compuestos lipopeptidos y metodos relacionados
EA201000089A1 (ru) Применение гомо- и сополимеров для стабилизации составов активных ингредиентов
IN2014CN04530A (da)
BR112012004335A8 (pt) Composto, composição farmacêutica, e, uso do composto.
EA201270216A1 (ru) Фармацевтический состав
ME01279B (me) Poboljšani rekonstituisani preparat surfaktanta koji sadži analoge surfaktantnog proteina b (sp-b) i surfaktantnog proteina c (sp-c)
EA201290374A1 (ru) Аэрозольная композиция для copd
BR112012014721A2 (pt) composição de hormônio do crescimento
MX353847B (es) Composicion farmaceutica de rosuvastatina calcica.
AR081165A1 (es) Composicion dental
SG158091A1 (en) Imidazoazepinone compounds
PE20140621A1 (es) Mejoras en o relacionadas con composiciones cementicias
DOP2010000329A (es) Inhibidores de la renina
MX2009008028A (es) Agentes antiparasitarios.